Diabetes Management
Management Topics (6)
Type 2 Diabetes Remission and Reversal Strategies
Until 2021 there was no agreed definition of type 2 diabetes remission; a consensus statement published that year set one.
Read the deep dive →Hemoglobin A1c, Fructosamine, and Glycation Markers
Glycation markers are measurements of how much sugar has stuck to specific proteins over specific time windows.
Read the deep dive →Cardio-Renal Protection: Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Agonists
How the cardiovascular safety trials required of every new glucose-lowering drug for type 2 diabetes since 2008 came to report protection of the heart and kidneys.
Read the deep dive →Insulin Types and Dosing Strategies
A healthy pancreas releases insulin as a slow background drip and as fast bursts at every meal; insulin by injection is an attempt to recreate both patterns.
Read the deep dive →Continuous Glucose Monitoring (CGM) and Time-in-Range for Diabetes
A continuous glucose monitor reports a glucose reading every one to five minutes, day and night, where hemoglobin A1c is a three-month average.
Read the deep dive →Once-Weekly Basal Insulins: Insulin Icodec and Insulin Efsitora
Two newer background (basal) insulins, insulin icodec and insulin efsitora alfa, are built to last a full week; this page gathers what the large trials found.
Read the deep dive →These pages report how diabetes is treated and tracked: the insulins and how their doses are set, the drug classes studied for protection of the heart and kidneys, what remission of type 2 diabetes means, and the measures used to follow glucose from minute to minute and over months. Each page reports what the trials and guidelines found.